Hosted on MSN27d
15 Inhalers for COPD
These medications are inhaled through ... by whether or not they help prevent symptoms or treat a COPD exacerbation. Preventers or maintenance inhalers are meant to be used daily over the long ...
Everyday Health24d
FDA Approves Dupixent for Some Patients Struggling With COPD Symptoms
Dupixent is an “add-on” maintenance therapy that these patients ... “We have good medications for COPD and most patients respond and their shortness of breath improves and their ability ...
clinicaladvisor.com20d
Dupixent Approved as Add-On Maintenance Therapy in COPD
The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD ...
Medscape20d
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with inhaler ...
pharmaphorum7d
Verona’s first-in-class COPD drug ‘could transform market’
Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... mechanism of action available for the maintenance treatment of COPD in more ...
Wall Street Journal24d
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron and Sanofi on Friday said the green light covers Dupixent as an add-on maintenance treatment in certain adults with uncontrolled chronic obstructive pulmonary disease, or COPD ...
WYOU11d
Sanofi and Regeneron introduces medication for COPD
Joining us is the company Sanofi and Regeneron to talk to us more about COPD also known as Chronic Obstructive Pulmonary ...
Medical Xpress19d
FDA approves Dupixent for chronic obstructive pulmonary disease
The U.S. Food and Drug Administration ... as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.
pharmaphorum2d
Verona cues up filings for COPD drug after it aces phase 3 test
The drug was administered twice-daily using a nebuliser as a chronic maintenance therapy for people with COPD in the ENHANCE-2 study, cutting the rate of moderate to severe exacerbations ...
Yahoo Finance24d
FDA, after delay, clears Regeneron and Sanofi drug for COPD
Dupixent is now cleared for use as an add-on maintenance treatment ... obstructive pulmonary disease, or COPD, that can’t be controlled with other medications. The decision makes Dupixent ...
Business Insider23d
Regeneron, Sanofi's Dupixent Get FDA Approval For Chronic Obstructive Pulmonary Disease Treatment
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY), Friday announced that the U.S. Food and Drug ... an add-on maintenance treatment for adults with uncontrolled COPD ...
EURACTIV4d
Improving COPD patients’ lives needs better diagnosis, drugs, devices
Patients with COPD often experience chronic cough, difficulty breathing, and reduced lung function. While the respiratory disease is not curable, it can be treated and managed with medications ...